Hutch News

Hutch News

Stories tagged 'gene therapy'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 29, 2017

Dr. Jennifer Adair, a clinical researcher at Fred Hutch, spoke recently at TEDxNashville about her vision of making gene therapy more accessible and affordable for treating diseases ranging from glioblastoma to HIV.

View story >


New nanoparticles make targeted, temporary gene therapy possible

‘Hit-and-run’ technology could improve immunotherapy and HIV cure research

Aug. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

'Hit-and-run' technology could improve immunotherapy and HIV cure research

View story >


Cake, candles and a wish for more HIV cures

An HIV workshop pays tribute to Timothy Ray Brown, whose cure 10 years ago fueled research — and hope

Feb. 13, 2017 | By Mary Engel / Fred Hutch News Service

At an HIV cure workshop, activists and researchers celebrated Timothy Ray Brown's 10th 'birthday.' A decade ago, Brown became the first and so far only person in the world to be cured of HIV after undergoing grueling bone marrow transplants to treat life-threatening leukemia. Over and over again on Sunday, he heard people say, "Timothy, you give me hope."

View story >


'Can't sit and wait': Gene therapy trial aims to cure rare Fanconi anemia

At annual hematology meeting, Fred Hutch researchers updated their treatment of 11-year-old Behzad

Dec. 4, 2016 | By Bill Briggs / Fred Hutch News Service

Behzad, 11, and his mom traveled from Mumbai, India to Seattle so he could be the first child to enroll in a Phase 1 Fred Hutch gene therapy study to try to correct his Fanconi anemia.

View story >


Gene therapy goes global: Portable device could make future cancer, HIV cures affordable

Portable 'gene therapy in a box' could make future cancer, HIV cures affordable in developing countries

Oct. 20, 2016 | By Mary Engel / Fred Hutch News Service

"Gene therapy in a box," developed by Fred Hutch's Dr. Jennifer Adair, suggests a solution to one of the most vexing challenges of gene therapy: How to make these emerging, high-tech treatments accessible and affordable beyond a handful of specialized research centers to clinics worldwide.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.